Recovery from impaired muscle growth arises from prolonged postnatal accretion of myonuclei in Atrx mutant mice

PloS One
Michael S HuhDavid J Picketts

Abstract

Reduced muscle mass due to pathological development can occur through several mechanisms, including the loss or reduced proliferation of muscle stem cells. Muscle-specific ablation of the α-thalassemia mental retardation syndrome mutant protein, Atrx, in transgenic mice results in animals with a severely reduced muscle mass at three weeks of age; yet this muscle mass reduction resolves by adult age. Here, we explore the cellular mechanism underlying this effect. Analysis of Atrx mutant mice included testing for grip strength and rotorod performance. Muscle fiber length, fiber volume and numbers of myofiber-associated nuclei were determined from individual EDL or soleus myofibers isolated at three, five, or eight weeks. Myofibers from three week old Atrx mutant mice are smaller with fewer myofiber-associated nuclei and reduced volume compared to control animals, despite similar fiber numbers. Nonetheless, the grip strength of Atrx mutant mice was comparable to control mice when adjusted for body weight. Myofiber volume remained smaller at five weeks, becoming comparable to controls by 8 weeks of age. Concomitantly, increased numbers of myofiber-associated nuclei and Ki67+ myoblasts indicated that the recovery of muscle mass like...Continue Reading

References

Jan 30, 1995·American Journal of Medical Genetics·R J GibbonsH M Kingston
Nov 13, 2001·Developmental Cell·P SealeM A Rudnicki
Sep 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yutong XueWeidong Wang
May 26, 2006·Orphanet Journal of Rare Diseases·Richard Gibbons
Jun 2, 2007·Cell·Shihuan KuangMichael A Rudnicki
Jan 8, 2008·Cell Metabolism·Antonio L SerranoPura Muñoz-Cánoves
Mar 29, 2008·Cell Stem Cell·Shihuan KuangMichael A Rudnicki
Feb 24, 2010·BMC Developmental Biology·Robert B WhitePeter S Zammit
Jun 18, 2010·Experimental Cell Research·Sonia Albini, Pier Lorenzo Puri
Jul 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peter W LewisC David Allis
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Se-Jin LeeChen-Ming Fan
Nov 2, 2012·The Journal of Clinical Investigation·Michael S HuhDavid J Picketts
Apr 9, 2013·The Journal of Clinical Investigation·L Ashley WatsonNathalie G Bérubé
Feb 1, 2014·The Journal of Biological Chemistry·Shin FujimakiTomoko Kuwabara
Mar 22, 2014·PloS One·Jeffrey S OtisSimon J Lees
Nov 17, 2015·Nature Medicine·Nicolas A DumontMichael A Rudnicki
May 14, 2016·Cell Death & Disease·M S HuhD J Picketts
Aug 18, 2016·Development·Ingrid M EgnerKristian Gundersen
Nov 4, 2016·EMBO Molecular Medicine·Emilia Servián-MorillaCarmen Paradas

❮ Previous
Next ❯

Citations

Jul 6, 2019·Journal of Neuroinflammation·Kevin G YoungDavid J Picketts
Nov 13, 2020·Scientific Reports·Nicole D ParisJoe V Chakkalakal
Apr 4, 2021·The FEBS Journal·John F Bachman, Joe V Chakkalakal

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy

Software Mentioned

ImageJ
ARRIVE
Adobe Photoshop
Axiovision

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
G PallafacchinaS Schiaffino
Proceedings of the Society for Experimental Biology and Medicine
D R CampionD R Romsos
© 2022 Meta ULC. All rights reserved